LOAN AND SECURITY AGREEMENTLoan and Security Agreement • June 14th, 2019 • Urovant Sciences Ltd. • Pharmaceutical preparations • California
THIS LOAN AND SECURITY AGREEMENT is made and dated as of February 20, 2019 and is entered into by and between Urovant Sciences Ltd., an exempted company limited by shares and organized under the laws of Bermuda (“Parent”), Urovant Holdings Limited, a private limited company incorporated under the laws of England and Wales (“Urovant England”), Urovant Sciences GmbH, a limited liability company (Gesellschaft mit beschränkter Haftung) incorporated and organized under the laws of Switzerland (“Urovant Switzerland”, and each of Parent’s Subsidiaries that delivers a Joinder Agreement pursuant to Section 7.13 of the Agreement (hereinafter collectively referred to as the “Borrowers” and each, a “Borrower”), Urovant Sciences, Inc., a Delaware corporation (“Urovant USA” or the “Guarantor”), the several banks and other financial institutions or entities from time to time parties to this Agreement (collectively, referred to as “Lender”) and HERCULES CAPITAL, INC., formerly known as Hercules Techno
UNCONDITIONAL SECURED GUARANTYUnconditional Secured Guaranty • June 14th, 2019 • Urovant Sciences Ltd. • Pharmaceutical preparations • California
This UNCONDITIONAL SECURED GUARANTY (this “Guaranty”) is entered into as of February 20, 2019, by Urovant Sciences, Inc., a Delaware corporation (“Guarantor”) in favor of Hercules Capital, Inc., a Maryland corporation, in its capacity as administrative agent and collateral agent for itself and the Lender (as defined below) (together with its successors and assigns in such capacity, “Agent”, and together with the Lender, collectively, “Secured Parties” and each a “Secured Party”).
